A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
for Breast Neoplasms
34 locations incl. Daphne
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT07060807·Phase 3·Recruiting·Listed Jul 2025
JPS Health Network
Clinical research site in Fort Worth, Texas · 1500 S MAIN ST, FORT WORTH, TX 76104-4917 · (817) 702-3000 · Website
As of July 2026, 7 paid clinical trials are recruiting at JPS Health Network in Fort Worth, Texas. Active studies at this site cover conditions such as Asthma, Asthma Attack and Asthma Exacerbations. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at JPS Health Network (7)
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for Carcinoma, Non-Small-Cell Lung
129 locations incl. Daphne
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06667076·Phase 2·Recruiting·Listed Oct 2024
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
for Breast Cancer
54 locations incl. Phoenix
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT06790693·Phase 3·Recruiting·Listed Jan 2025
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
for Non-Small Cell Lung Cancer
50 locations incl. Anchorage
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT06793215·Phase 3·Recruiting·Listed Jan 2025
An Extension Study to Assess Long-Term Safety and Tolerability of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia
for Schizophrenia
37 locations incl. Phoenix
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All·Age: 18 - 65
Code: NCT05304767·Phase 3·Recruiting·Listed Mar 2022
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
for Metastatic Breast Cancer
16 locations incl. Gilbert
Sponsor: Hoffmann-La Roche
Sex: All·Age: 18+
Code: NCT05894239·Phase 3·Recruiting·Listed Jun 2023
Individualizing Treatment for Asthma in Primary Care (Full Study)
for Asthma
13 locations incl. Aurora
Sponsor: DARTNet Institute
Sex: All·Age: 13 - 75
Code: NCT07052942·Phase 4·Recruiting·Listed Jul 2025
More research sites in Fort Worth
- Cook Children's Medical Center (56 trials)
- UT Southwestern/Simmons Cancer Center-Fort Worth (25 trials)
- Cook Children's Health Care System (11 trials)
- Re:Cognition Health - Fort Worth (8 trials)
- Cook Children's Hospital (6 trials)
- Texas Christian University (5 trials)
- Baylor All Saints Medical Center (4 trials)
- GI Alliance - Fort Worth (4 trials)
- John Peter Smith Hospital (4 trials)
- START Dallas (4 trials)
Explore more
Paid clinical trials in Fort Worth, TX · Texas clinical trials